Page last updated: 2024-10-24

positive regulation of hair cycle

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair. [GOC:go_curators, PMID:12230507]

The positive regulation of hair cycle is a complex and tightly controlled process involving multiple signaling pathways, cellular interactions, and molecular mechanisms. It is essential for maintaining healthy hair growth and preventing alopecia.

The hair cycle is characterized by three distinct phases: anagen (growth), catagen (regression), and telogen (resting). Each phase is regulated by intricate signaling networks that involve various growth factors, hormones, and transcription factors.

During anagen, hair follicles undergo rapid growth and proliferation, resulting in the formation of new hair shafts. This phase is initiated by signals from the dermal papilla, a specialized structure located at the base of the hair follicle. The dermal papilla contains fibroblasts that produce growth factors, such as fibroblast growth factor (FGF) and insulin-like growth factor (IGF), which stimulate hair follicle stem cells to enter the anagen phase.

FGF7 and FGF10 are key players in the anagen induction and hair follicle development. They activate the Wnt signaling pathway, which promotes the proliferation and differentiation of hair follicle cells. IGF-1 also plays a critical role in anagen initiation by promoting the expression of growth factors and transcription factors involved in hair growth.

The hair cycle is also regulated by hormones, such as androgen and estrogen. Androgen, particularly testosterone, stimulates hair growth in certain areas of the body, while estrogen promotes hair growth in others. However, the exact mechanisms by which hormones regulate hair growth are complex and still under investigation.

During catagen, hair follicle growth slows down, and the hair shaft detaches from the follicle. This transition is triggered by a decrease in FGF and IGF levels and an increase in transforming growth factor-beta (TGF-beta) signaling. TGF-beta promotes apoptosis (cell death) in hair follicle cells, leading to the regression of the hair follicle.

In the telogen phase, hair follicles remain dormant and the hair shaft detaches completely from the follicle. This phase is characterized by low levels of growth factors and high levels of TGF-beta.

Several cellular interactions are involved in the positive regulation of hair cycle. For example, interactions between hair follicle stem cells and dermal papilla fibroblasts are essential for hair growth. Signals from the dermal papilla can influence the fate of hair follicle stem cells, promoting their proliferation and differentiation into hair follicle cells.

In addition to signaling pathways and cellular interactions, the expression of various genes and transcription factors is crucial for the positive regulation of hair cycle. These include genes involved in cell proliferation, differentiation, and apoptosis, as well as transcription factors that regulate the expression of these genes.

Disruption of the positive regulation of hair cycle can lead to alopecia, or hair loss. This can be caused by various factors, including genetics, hormonal imbalances, medications, and stress. Understanding the intricate mechanisms involved in hair cycle regulation is essential for developing new therapies to prevent and treat hair loss.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Telomerase reverse transcriptaseA telomerase reverse transcriptase that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14746]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
7,8-dihydroxyflavone7,8-dihydroxyflavone : A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A dihydroxyflavone that is flavone substituted by hydroxy groups at positions 7 and 8. A naturally occurring flavonoid produced by several plants, including the weed Tridax procumbens (coalbuttons or tridax daisy) and the tree Godmania aesculifolia, In animal models, it has shown efficacy against several diseases of the nervous system, including Alzheimer's, Parkinson's, and Huntington's.dihydroxyflavoneantidepressant;
antineoplastic agent;
antioxidant;
plant metabolite;
tropomyosin-related kinase B receptor agonist
ethacridineEthacridine: A topically applied anti-infective agent.acridines
berberinealkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound
antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
9,10-phenanthrenequinone9,10-phenanthrenequinone: structurephenanthrenes
ethidium bromideorganic bromide saltgeroprotector;
intercalator;
trypanocidal drug
camptothecinNSC 100880: carboxylate (opened lactone) form of camptothecin; RN refers to (S)-isomer; structure given in first sourcedelta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
staurosporineindolocarbazole alkaloid;
organic heterooctacyclic compound
apoptosis inducer;
bacterial metabolite;
EC 2.7.11.13 (protein kinase C) inhibitor;
geroprotector
acridine orangeacridine orange : Fluorescent dye useful for cell cycle determination. It is cell-permeable, and interacts with DNA and RNA by intercalation or electrostatic attractions respectively.

acridine orange free base : A member of the class of aminoacridines that is acridine carrying two dimethylamino substituents at positions 3 and 6. The hydrochloride salt is the fluorescent dye 'acridine orange', used for cell cycle determination.

Acridine Orange: A cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms.
aminoacridines;
aromatic amine;
tertiary amino compound
fluorochrome;
histological dye
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
meridinemeridine: polycyclic alkaloid derived from the marine sponge Corticium sp; structure given in first source
cryptolepinecryptolepine : An organic heterotetracyclic compound that is 5H-indolo[3,2-b]quinoline in which the hydrogen at position N-5 is replaced by a methyl group.

cryptolepine: fused indole-quinoline; structure in first source; from CRYPTOLEPIS sanguinolenta
indole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
cysteine protease inhibitor;
plant metabolite
quindolinequindoline: a fused indole-quinoline alkaloid from CRYPTOLEPIS sanguinolenta; structure
u 731221-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione: structure given in first source

U-73122 : An aza-steroid that is 3-O-methyl-17beta-estradiol in which the 17beta-hydroxy group is replaced by a 6-(maleimid-1-yl)hexylamino group. An inibitor of phospholipase C.
aromatic ether;
aza-steroid;
maleimides
EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
alteichinalteichin: unusual phytotoxin from Alternaria eichorniae, fungal pathogen of water hyacinth; doubly hydrated form of 4,9-dihydroxyperylene-3,10-quinonepolyphenol
3',4'-dihydroxyflavone3',4'-dihydroxyflavone: inhibitors of arachidonic acid peroxidation
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
Telomestatin1,3-oxazoles
7,8,3'-trihydroxyflavone7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-oneflavones
7,8,4'-trihydroxyflavone
okaninokanin : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 3, 4, 2', 3', and 4' respectively.

okanin: hypoglycemic from Coreopsis tinctoria; structure in first source
benzenetriol;
chalcones
plant metabolite
3',4',7-trihydroxyflavone3',4',7-trihydroxyflavone: from the Sudanese medicinal plant Albizia zygia; structure in first sourceflavones
beta-rubromycinbeta-rubromycin: structure given in first source
mkt 077MKT 077: structure given in first source
braco-19BRACO-19: structure in first sourceacridines;
N-alkylpyrrolidine
bibr 1532
n'-(10h-indolo(3,2-b)quinolin-11-yl)-n,n-dimethylpropane-1,3-diamine